RBM15 exhibits a well-established oncogenic role in the development of hematologic malignancies [112] and is a fusion partner of the MKL1 gene in acute megakaryoblastic leukemia, a subtype of pediatric AML [113]. Here, RBM15 is linked to acute myeloid leukemia.